This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT05154240
Recruitment Status : Completed
First Posted : December 13, 2021
Last Update Posted : June 29, 2023
Information provided by (Responsible Party):
InSilico Medicine Hong Kong Limited

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2, 2022
Actual Study Completion Date : December 2, 2022